Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Acquires Canopy Biosciences

NEW YORK — Bruker said on Friday that it has acquired Canopy Biosciences in a bid to expand its portfolio of targeted multi-omics and fluorescence-based imaging technologies.

Founded in 2016, Canopy provides a range of products and services for gene editing, gene expression analysis and regulation, and bioprocessing including custom cell-line engineering. The St. Louis-based company has also developed a multi-omic platform for immune profiling that includes DNA and RNA sequencing, as well as multiplexed protein detection based on the ChipCytometry technology it acquired through its purchase of German cytometry firm Zellkraftwerk last year.

Financial terms of the transaction were not disclosed.

"We are excited to add the multi-omics and high-content cytometry expertise of Canopy and its novel ChipCytometry platform to Bruker," Mark Munch, president of Bruker's Nano group, said in a statement. "Canopy has a unique set of products that enable single cell, tissue, and suspended cell-based discovery and validation in immunology and targeted proteomics, as well as a suite of complementary multi-omics services."

Last month, Billerica, Massachusetts-based Bruker reported a 13 percent drop in second quarter revenues, however its life science mass spectrometry business was strong.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.